News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,450 Results
Type
Article (8376)
Company Profile (140)
Press Release (477933)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (167449)
Career Advice (342)
Deals (25842)
Drug Delivery (9)
Drug Development (53083)
Employer Resources (14)
FDA (9809)
Job Trends (8633)
News (239158)
Policy (18009)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (516)
Accelerated approval (23)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33360)
ALS (103)
Alzheimer's disease (988)
Antibody-drug conjugate (ADC) (261)
Approvals (10401)
Artificial intelligence (323)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (7002)
BIO (37)
BIOSECURE Act (1)
Biosimilars (107)
BioSpace Insights (19)
Biotechnology (88)
Bladder cancer (149)
Brain cancer (28)
Breast cancer (510)
Cancer (3661)
Cardiovascular disease (219)
Career advice (278)
Career pathing (2)
CAR-T (174)
Celiac Disease (1)
Cell therapy (479)
Cervical cancer (34)
Clinical research (47979)
Collaboration (1240)
Commercialization (2)
Compensation (1427)
Complete response letters (34)
COVID-19 (777)
CRISPR (63)
C-suite (732)
Cystic fibrosis (86)
Data (5612)
Denatured (4)
Depression (105)
Dermatology (60)
Diabetes (343)
Diagnostics (4196)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73611)
Editorial (1)
Employer branding (2)
Employer resources (15)
Events (87859)
Executive appointments (702)
FDA (12411)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (912)
Gene editing (125)
Generative AI (9)
Gene therapy (320)
GLP-1 (295)
Government (971)
Grass and pollen (2)
Guidances (281)
Healthcare (9443)
Hematology (96)
HIV (52)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (100)
Immuno-oncology (56)
Indications (157)
Infectious disease (967)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (251)
Interviews (52)
IPO (12446)
IRA (2)
Job creations (1988)
Job search strategy (257)
JPM (1)
Kidney cancer (16)
Layoffs (62)
Leadership (1)
Legal (5218)
Licensing (5)
Liver cancer (46)
Longevity (16)
Lung cancer (502)
Lymphoma (255)
Machine learning (29)
Management (3)
Manufacturing (533)
Marketing (7)
MASH (119)
Medical device (8711)
Medtech (8847)
Mergers & acquisitions (14424)
Metabolic disorders (708)
mRNA (58)
Multiple sclerosis (102)
NASH (5)
Neurodegenerative disease (223)
Neuropsychiatric disorders (40)
Neuroscience (1834)
NextGen: Class of 2026 (3189)
Non-profit (919)
Obesity (225)
Opinion (16)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (193)
Parkinson's disease (201)
Partnered (11)
Patents (468)
Patient recruitment (497)
Peanut (31)
People (41402)
Pharmaceutical (31)
Pharmacy benefit managers (8)
Phase 1 (15520)
Phase 2 (21439)
Phase 3 (14425)
Pipeline (7023)
Policy (19)
Postmarket research (1578)
Preclinical (6548)
Press Release (36)
Prostate cancer (188)
Psychedelics (8)
Radiopharmaceuticals (192)
Rare diseases (573)
Real estate (3058)
Recruiting (7)
Regulatory (14869)
Reports (18)
Research institute (599)
Resumes & cover letters (54)
Rett syndrome (41)
RNA editing (5)
RSV (50)
Schizophrenia (99)
Series A (154)
Series B (120)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2053)
Stomach cancer (3)
Supply chain (50)
The Weekly (1)
Vaccines (329)
Venture capital (18)
Weight loss (76)
Women's health (76)
Worklife (2)
Date
Today (11)
Last 7 days (508)
Last 30 days (1458)
Last 365 days (19227)
2026 (11701)
2025 (19391)
2024 (23149)
2023 (26741)
2022 (34815)
2021 (37389)
2020 (33724)
2019 (23520)
2018 (17636)
2017 (18866)
2016 (18041)
2015 (24388)
2014 (21794)
2013 (18193)
2012 (20264)
2011 (20497)
2010 (20363)
Location
Africa (233)
Alabama (72)
Alaska (2)
Arizona (299)
Arkansas (11)
Asia (18023)
Australia (2122)
California (11814)
Canada (3121)
China (511)
Colorado (475)
Connecticut (403)
Delaware (205)
Europe (25048)
Florida (1755)
Georgia (370)
Hawaii (3)
Idaho (46)
Illinois (695)
India (45)
Indiana (315)
Iowa (14)
Japan (397)
Kansas (99)
Kentucky (30)
Louisiana (26)
Maine (25)
Maryland (1180)
Massachusetts (7776)
Michigan (304)
Minnesota (557)
Mississippi (4)
Missouri (79)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (61)
New Jersey (2617)
New Mexico (12)
New York (2813)
North Carolina (1257)
North Dakota (4)
Northern California (5898)
Ohio (276)
Oklahoma (14)
Oregon (17)
Pennsylvania (2234)
Puerto Rico (20)
Rhode Island (31)
South America (451)
South Carolina (76)
South Dakota (1)
Southern California (4900)
Tennessee (117)
Texas (1903)
United States (38438)
Utah (356)
Vermont (1)
Virginia (155)
Washington D.C. (38)
Washington State (913)
West Virginia (1)
Wisconsin (74)
486,450 Results for "envision inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Envision Pharma Group appoints Nick Jones as President, Envision Medical Communications
April 8, 2026
·
2 min read
Press Releases
Envision Pharma Group Strengthens Executive Leadership Team to Accelerate Growth, Innovation and Global Client Delivery
April 15, 2026
·
3 min read
Press Releases
ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing
June 19, 2026
·
4 min read
Press Releases
ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
May 13, 2026
·
10 min read
Press Releases
Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI
March 30, 2026
·
9 min read
Business
Envision Pharma Group Announces the Appointment of Alistair Macdonald to Board of Directors
Envision Pharma Group announced the appointment of Alistair Macdonald to the Envision Board of Directors.
May 8, 2024
·
2 min read
Press Releases
Western Blotting Market to Envision USD 3.60 Billion by 2034
August 26, 2025
·
1 min read
Manufacturing
BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot
BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other modalities while mRNA technology continues to face headwinds in the U.S.
April 3, 2026
·
2 min read
·
Nick Paul Taylor
Business
Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer
Envision Pharma Group (Envision) has appointed Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team.
January 18, 2024
·
2 min read
Approvals
Vanda Ends 40-Year Motion Sickness Drug Drought With FDA Approval for Nereus
Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are dissatisfied with existing treatments.
January 2, 2026
·
3 min read
·
Nick Paul Taylor
1 of 48,645
Next
